NXPE3

Model summary

A secreted human extracellular binder that uses an Ig-like core and a specialized C-terminal module to assemble and tune receptor-centered complexes outside the cell. By organizing multivalent interactions with surface receptors and matrix components, it dampens canonical Wnt signaling and is likely trafficked and concentrated via extracellular vesicles, where it modulates pathway flux at cell–cell and cell–matrix interfaces.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture.

   The central region from residues 74–275 carries IPR026845 (Neurexophilin/NXPE family), establishing membership in a secreted ligand family that modulates synaptic and developmental signaling. Nested within this family scaffold, residues 102–187 form IPR014756 (Immunoglobulin E-set homologous superfamily), an Ig-like beta-sandwich that creates a rigid, solvent-exposed binding surface optimized for avid, multivalent protein–protein interactions rather than catalysis. The C-terminal half (residues 331–555) comprises IPR057106 (NXPE, C-terminal domain), a hallmark tail that stabilizes NXPE fold and provides additional interfaces for receptor or matrix engagement. The ordered layout—an Ig-like binding core embedded in a neurexophilin/NXPE framework and capped by a specialized NXPE C-terminus—causes the polypeptide to function as a secreted, non-enzymatic binder that assembles and tunes extracellular signaling complexes. This architecture dictates GO:0005515 protein binding as the primary molecular function.

2. 02

   A secreted Ig-like binder typically shapes pathway flux by clustering or sequestering extracellular receptors and co-receptors.

   The neurexophilin/NXPE lineage is known to modulate cell–cell and cell–matrix communication; here, the Ig E-set and NXPE tail together create a platform that can dampen pathway throughput by stabilizing inhibitory assemblies. Such a mechanism naturally explains negative control over the canonical Wnt cascade: by promoting assemblies that favor non-canonical routing or receptor sequestration, the protein attenuates beta-catenin–dependent transcriptional signaling. This causal chain aligns with GO:0090090 negative regulation of canonical Wnt signaling pathway.

3. 03

   The absence of transmembrane motifs and the presence of a secreted-ligand architecture place the protein outside the cell.

   Its secretion and stable association with vesicle cargoes and receptor-rich niches support extracellular residency and packaging into vesicles. This reasoning converges on extracellular vesicle association, consistent with GO:0070062 extracellular exosome, and with a broader secreted/extracellular localization.

4. 04

   Mechanistically, I hypothesize that the Ig-like core nucleates transient complexes with cell-surface receptors and extracellular matrix components, while the NXPE C-terminus refines specificity and avidity.

   By docking to Wnt receptor modules (e.g., Frizzled/LRP complexes) and to matrix or co-receptors, the protein likely shifts signaling equilibria toward inhibition of canonical outputs. It may also be delivered and concentrated via exosomes, which provide a route to extracellular hotspots. Candidate partners include neurexin-family or Wnt-pathway receptor assemblies, heparan sulfate proteoglycans that scaffold ligand–receptor clusters, and exosome biogenesis machinery that chaperones its secretion and extracellular deposition.